Synopsis of recent research by authors named "Bo-Siang Fu"
- Bo-Siang Fu's research focuses on the development of novel diagnostic techniques and therapeutic approaches in cancer treatment, specifically targeting genetic variants associated with chronic myeloid leukemia and osteosarcoma.
- In a significant 2022 study, Fu introduced a method utilizing copper nanoclusters for the label-free fluorescent sensing of the T315I mutation in the BCR-ABL gene, emphasizing its clinical importance due to its resistance to tyrosine kinase inhibitors.
- Another notable investigation involved the effects of Sorafenib on osteosarcoma cells, revealing its role in inducing apoptosis and inhibiting NF-κB pathways, which could contribute to better management strategies for this hard-to-treat cancer.
